CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 59  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0904
LYS 10.0475
GLU 20.0552
LEU 30.0262
ARG 40.0398
CYS 50.0356
GLN 60.0199
CYS 70.0093
ILE 80.0681
LYS 90.0490
THR 100.0190
TYR 110.0308
SER 120.0339
LYS 130.0237
PRO 140.0135
PHE 150.0067
HIS 160.0311
PRO 170.0132
LYS 180.0211
PHE 190.0148
ILE 200.0083
LYS 210.0022
GLU 220.0123
LEU 230.0109
ARG 240.0047
VAL 250.0105
ILE 260.0142
GLU 270.0142
SER 280.0200
GLY 290.0242
PRO 300.0096
HIS 310.0126
CYS 320.0069
ALA 330.0904
ASN 340.0400
THR 350.0125
GLU 360.0095
ILE 370.0107
ILE 380.0139
VAL 390.0139
LYS 400.0185
LEU 410.0089
SER 420.0043
ASP 430.0301
GLY 440.0126
ARG 450.0122
GLU 460.0193
LEU 470.0104
CYS 480.0075
LEU 490.0078
ASP 500.0163
PRO 510.0218
LYS 520.0307
GLU 530.0140
ASN 540.0071
TRP 550.0158
VAL 560.0165
GLN 570.0157
ARG 580.0100
VAL 590.0075
VAL 600.0089
GLU 610.0084
LYS 620.0124
PHE 630.0020
LEU 640.0094
LYS 650.0084
ARG 660.0098
ALA 670.0133
GLU 680.0141
ASN 690.0092

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.